Phathom Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 10.11 M | $82.09 M | 0.00% | 15.64% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2025 | 7.46 M | $60.61 M | 0.00% | 11.55% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 7.06 M | $57.35 M | 20.39% | 10.93% |
| INVESCO LTD. | 02/13/2025 | 3.67 M | $29.81 M | -10.38% | 5.68% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.50 M | $28.44 M | 12.16% | 5.42% |
| CARLYLE GROUP INC. | 02/13/2025 | 3.50 M | $28.39 M | 0.00% | 5.41% |
| VANGUARD GROUP INC | 02/11/2025 | 2.78 M | $22.57 M | 3.09% | 4.30% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 2.53 M | $20.52 M | -2.10% | 3.91% |
| CHECKPOINT CAPITAL L.P. | 02/14/2025 | 2.27 M | $18.47 M | 51.18% | 3.52% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 1.96 M | $15.92 M | 0.00% | 3.03% |
| WASATCH ADVISORS LP | 02/13/2025 | 1.56 M | $12.66 M | 531.29% | 2.41% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 1.39 M | $11.29 M | -22.96% | 2.15% |
| CATALYS PACIFIC, LLC | 02/14/2025 | 1.17 M | $9.48 M | 3.97% | 1.81% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 1.10 M | $8.96 M | -2.07% | 1.71% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.03 M | $8.32 M | 1.49% | 1.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.02 M | $8.27 M | 18.03% | 1.58% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.00 M | $8.13 M | -61.08% | 1.55% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 989,927 | $8.04 M | 13.79% | 1.53% |
| FMR LLC | 02/13/2025 | 801,401 | $6.51 M | -38.55% | 1.24% |
| DECHENG CAPITAL LLC | 02/14/2025 | 694,254 | $5.64 M | -44.46% | 1.07% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 581,935 | $4.73 M | 11.50% | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 500,000 | $4.06 M | 100.00% | 0.77% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 485,790 | $3.94 M | 215.39% | 0.75% |
| UBS GROUP AG | 02/14/2025 | 465,616 | $3.78 M | 547.22% | 0.72% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 463,340 | $3.76 M | 11.56% | 0.72% |
| SIREN, L.L.C. | 02/14/2025 | 460,753 | $3.74 M | 0.00% | 0.71% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 455,837 | $3.70 M | 100.00% | 0.71% |
| STEPSTONE GROUP LP | 02/13/2025 | 422,085 | $3.43 M | 0.00% | 0.65% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 412,262 | $3.35 M | -5.06% | 0.64% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 378,637 | $3.07 M | 100.00% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 353,038 | $2.87 M | 20.55% | 0.55% |
| JANE STREET GROUP, LLC | 02/14/2025 | 287,800 | $2.34 M | 100.00% | 0.45% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 282,553 | $2.29 M | 100.00% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 257,400 | $2.09 M | 1,306.56% | 0.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 235,404 | $1.91 M | 31.75% | 0.36% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 147,523 | $1.20 M | -4.44% | 0.23% |
| ORACLE INVESTMENT MANAGEMENT INC | 02/14/2025 | 145,064 | $1.18 M | -80.64% | 0.22% |
| JPMORGAN CHASE & CO | 02/12/2025 | 136,907 | $1.11 M | 1.09% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 135,995 | $1.10 M | -21.56% | 0.21% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 133,700 | $1.09 M | 100.00% | 0.21% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 132,269 | $1.07 M | 61.76% | 0.20% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 117,803 | $956,561 | 20.18% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 102,748 | $834,317 | 4.64% | 0.16% |
| MARSHALL WACE, LLP | 02/13/2025 | 98,068 | $796,312 | 100.00% | 0.15% |
| JANE STREET GROUP, LLC | 02/14/2025 | 77,869 | $632,296 | 179.68% | 0.12% |
| BARCLAYS PLC | 02/13/2025 | 76,463 | $621,000 | 32.27% | 0.12% |
| SWISS NATIONAL BANK | 02/10/2025 | 73,300 | $595,196 | 0.00% | 0.11% |
| SUMMIT FINANCIAL WEALTH ADVISORS, LLC | 02/13/2025 | 68,125 | $383,544 | 134.65% | 0.11% |
| PENN MUTUAL ASSET MANAGEMENT, LLC | 02/14/2025 | 62,802 | $509,952 | 0.00% | 0.10% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 59,991 | $487,127 | 82.19% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 175 institutional investors and hedge funds held shares of Phathom Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 10.11 M
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
JENNISON ASSOCIATES LLC: 7.06 M
Invesco Ltd.: 3.67 M
BlackRock Funding, Inc. /DE: 3.5 M
Carlyle Group Inc.: 3.5 M
103.17% of Phathom Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 71.88 M shares in the last 24 months. This purchase volume represents approximately $547.02 M in transactions.